Correction to: The role of fibrinolysis inhibition in engineered vascular networks derived from endothelial cells and adipose-derived stem cells
The original article [1] contains numerous value errors in the graphs in Fig. 2b regarding the markers describing the values for total tubule length and mean tubule length without aprotinin at 2.5 mg/ml concentration of fibrinogen. The corrected version of this figure can be viewed ahead.
Main Authors: | Severin Mühleder, Karoline Pill, Mira Schaupper, Krystyna Labuda, Eleni Priglinger, Pablo Hofbauer, Verena Charwat, Uwe Marx, Heinz Redl, Wolfgang Holnthoner |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-10-01
|
Series: | Stem Cell Research & Therapy |
Online Access: | http://link.springer.com/article/10.1186/s13287-018-1001-3 |
Similar Items
-
The role of fibrinolysis inhibition in engineered vascular networks derived from endothelial cells and adipose-derived stem cells
by: Severin Mühleder, et al.
Published: (2018-02-01) -
Microvascular Networks From Endothelial Cells and Mesenchymal Stromal Cells From Adipose Tissue and Bone Marrow: A Comparison
by: Karoline Pill, et al.
Published: (2018-10-01) -
Cre mRNA Is Not Transferred by EVs from Endothelial and Adipose-Derived Stromal/Stem Cells during Vascular Network Formation
by: Jaana Schneider, et al.
Published: (2021-04-01) -
Vascularization mediated by mesenchymal stem cells from bone marrow and adipose tissue: a comparison
by: Karoline Pill, et al.
Published: (2015-01-01) -
Endothelial Extracellular Vesicles—Promises and Challenges
by: Carina Hromada, et al.
Published: (2017-05-01)